Hillsdale Investment Management Inc. Purchases Shares of 6,700 Agilent Technologies, Inc. $A

Hillsdale Investment Management Inc. bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,700 shares of the medical research company’s stock, valued at approximately $912,000.

Other institutional investors have also made changes to their positions in the company. Massachusetts Financial Services Co. MA raised its holdings in Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares in the last quarter. Wellington Management Group LLP increased its stake in Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after purchasing an additional 433,342 shares during the last quarter. Geode Capital Management LLC increased its stake in Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after purchasing an additional 25,139 shares during the last quarter. Generation Investment Management LLP increased its stake in Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after purchasing an additional 582,093 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in Agilent Technologies by 15.1% during the third quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock valued at $347,685,000 after purchasing an additional 354,480 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on A. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday. Robert W. Baird boosted their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. UBS Group lowered their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. TD Cowen upped their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price target for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $162.79.

Agilent Technologies Stock Performance

A stock opened at $136.08 on Tuesday. The company has a market capitalization of $38.46 billion, a P/E ratio of 27.33, a PEG ratio of 2.77 and a beta of 1.26. The company has a 50-day simple moving average of $116.42 and a 200 day simple moving average of $128.54. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.84 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.98 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.